Diagnostic Medical Systems S.A. (EPA: ALDMS)

Market Cap	12.56M
Revenue (ttm)	46.53M
Net Income (ttm)	-10.15M
Shares Out	18.10M
EPS (ttm)	-0.57
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,656
Open	0.690
Previous Close	0.682
Day's Range	0.640 - 0.732
52-Week Range	0.640 - 1.370
Beta	1.03
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 20, 2024

About EPA: ALDMS

Diagnostic Medical Systems S.A. operates in the medical imaging industry in France and internationally. The company offers radiography/fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D reconstruction, and mobile C-arms solutions. It also provides technologies for the treatment of osteoarthritis, and regenerative medicine based on the injection of fat stem cells. Diagnostic Medical Systems S.A. was founded in 1979 and is based in Mauguio, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1979
• Employees: 134
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALDMS

Financial Performance

In 2023, ALDMS's revenue was 44.12 million, an increase of 19.05% compared to the previous year's 37.06 million. Losses were -4.95 million, -27.48% less than in 2022.